Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / December / Reversing Amblyopia
Retina Latest Research & Innovations News

Reversing Amblyopia

MIT study offers new mechanistic insights into reversing the effects of long-term monocular deprivation

12/18/2025 3 min read

Share

Credit: AdobeStock.com

A new MIT study published in Cell Reports has offered mechanistic evidence that temporary retinal inactivation can reverse the effects of long-term monocular deprivation, even beyond the classical critical period. The research identifies a burst-firing mode in the dorsal lateral geniculate nucleus (dLGN) as the key driver that enables visual cortical recovery — reshaping how clinicians might think about treating refractory amblyopia.

Using a mouse model of deprivation amblyopia, the study authors showed that intravitreal tetrodotoxin (TTX) injected into one eye induces a dramatic shift in firing dynamics of dLGN neurons connected to the other eye. Neurons that were postsynaptic to the uninjected eye exhibited significantly shorter interspike intervals and a larger proportion of spikes occurring in high-frequency bursts — defined as ≥2 spikes within 4 ms following ≥100 ms of quiescence.

The effect was not subtle: bursting increased under both stimulated and spontaneous conditions and included a rise in longer, multi-spike bursts (3–4 spikes), suggesting a robust shift in network state.

To test causality, the team generated a thalamic T-channel knockout (TTKO) by deleting Cav3.1 locally in the dLGN. In these animals, TTX no longer induced burst firing, demonstrating that Cav3.1-mediated low-threshold calcium currents are necessary for burst-mode recruitment. Importantly, visual responsiveness and thalamocortical transmission remained otherwise intact.

The central question – does bursting enable recovery? – was answered using ocular dominance measurements in the primary visual cortex (V1). In wild-type mice subjected to long-term monocular deprivation, silencing the fellow eye with TTX fully reversed the ocular dominance shift. In contrast, TTKO mice failed to recover, despite identical treatment.

With these findings, the authors indicate that burst firing in the dLGN is required for the therapeutic effect of retinal inactivation.

An additional finding was that the amblyopic eye itself can be inactivated to drive recovery. A single injection of TTX into the deprived eye – without manipulating the fellow eye – restored ocular dominance indices to levels indistinguishable from normally reared animals. This suggests that burst-driven plasticity arises globally within the thalamus, independent of which eye is silenced.

The authors propose that retinal inactivation re-engages early developmental–like activity patterns, akin to the spontaneous bursting seen during critical-period circuit formation. Such activity may facilitate thalamocortical long-term potentiation, reduce inhibitory constraints in V1, or both.

Importantly, silencing the amblyopic eye – conceptually aligned with human “inverse occlusion” studies – may be more acceptable to patients than manipulating the healthy eye.

The study identifies dLGN burst mode firing as a mechanistic switch that reopens plasticity in the adult visual system. By demonstrating that retinal inactivation can restore synaptic strength after severe amblyogenic rearing – and revealing the dependence on Cav3.1-mediated bursting – the work lays a foundation for developing physiology-based amblyopia therapies that could benefit patients beyond the traditional critical period.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: